Elevation Oncology, Inc.
Elevation Oncology, Inc.（ELEV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
elev · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2025年11月5日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Hold
12 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$9.00
+2365.8% upside
Low
$8.00
Median: $9 · Last Close: $0.36
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ELEV · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-06-10 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-06-10 | JMP Securities | Maintains | Market Perform→Market Perform |
| 2025-06-09 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2025-03-24 | Stephens & Co. | Downgrade ↓ | Overweight→Equal Weight |
| 2025-03-21 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2025-03-21 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-21 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2025-03-21 | Citizens Capital Markets | Downgrade ↓ | Market Outperform→Market Perform |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Elevation Oncology, Inc. (ELEV) stock. Of the recent 38 rating actions, 1 were upgrades and 10 were downgrades. 12 analysts currently cover ELEV.
分析师推荐趋势
ELEV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-0.71
EPS Next Year
$-0.51
↓ 28.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ELEV EPS of $-0.71 for the current fiscal year, based on estimates from 4 analysts. The ELEV revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ELEV 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ELEV 的共识目标价为 $9.00（+2365.8% 上行空间），分析师共识为 Hold。
Elevation Oncology, Inc. 在 NASDAQ 上市，代码 ELEV。ELEV 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 25% 对应 Hold 共识。
常见问题
ELEV 预测 · 8 个问题根据 12 位华尔街分析师，ELEV 的 12 个月平均目标价为 $9.00，最高 $10.00、最低 $8.00。若有图表，中位目标价可在上方查看。相对当前价 $0.36，隐含约 +2365.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.